Lowering the risk of Parkinson's disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetes.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33103730.
- Also identified by DOI 10.1093/brain/awaa287 and PMC identifier 7586082.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This scientific commentary refers to ‘Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes’, by Brauer <i>etal.</i> (doi:10.1093/brain/awaa262).
Medical subject headings
- Diabetes Mellitus, Type 2
- Dipeptidyl-Peptidase IV Inhibitors
- Parkinson Disease